1.Y. Zhang*, J. Li*, L. Feng, Y. Cheng, L. Shi, Q. Yang, Z. Wang, X. Yi, G. Zhong, X. Sun, Z. Cheng, M. Guo. STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltration. Am J Cancer Res, 2024, 14(7):3294-3316
2.Wang Z, Zhu Q, Li X, Ren X, Li J, Zhang Y, Zeng S, Xu L, Dong X, Zhai B. TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib. American journal of cancer research, 2022, 12(9):4343-4360
